The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
10.79
-0.22 (-2.04%)
Aug 14, 2025, 1:44 PM - Market open
The Joint Market Cap
The Joint has a market cap or net worth of $165.48 million as of August 14, 2025. Its market cap has decreased by -22.71% in one year.
Market Cap
165.48M
Enterprise Value
141.29M
1-Year Change
-22.71%
Ranking
Category
Stock Price
$10.79
Market Cap Chart
Since November 11, 2014, The Joint's market cap has increased from $60.30M to $165.48M, an increase of 174.43%. That is a compound annual growth rate of 9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 170.00M | 6.72% |
| Dec 31, 2024 | 159.30M | 12.34% |
| Dec 29, 2023 | 141.80M | -30.18% |
| Dec 30, 2022 | 203.10M | -78.55% |
| Dec 31, 2021 | 946.80M | 156.79% |
| Dec 31, 2020 | 368.70M | 64.75% |
| Dec 31, 2019 | 223.80M | 95.80% |
| Dec 31, 2018 | 114.30M | 70.34% |
| Dec 29, 2017 | 67.10M | 99.11% |
| Dec 30, 2016 | 33.70M | -42.98% |
| Dec 31, 2015 | 59.10M | -4.68% |
| Dec 31, 2014 | 62.00M | 2.82% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 607.52B |
| Johnson & Johnson | 420.18B |
| AbbVie | 360.31B |
| UnitedHealth Group | 245.49B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.14B |